Artificial Intelligence-Driven Innovation in Cancer Surgery: A Systematic Review of Horizon Europe-Funded Projects

Abstract

Horizon Europe is the European Union's key funding program for research and innovation. It tackles climate change, helps achieve the UN's Sustainable Development Goals, and boosts the EU's competitiveness and growth. This study analyzes AI-driven innovation in cancer surgery through projects funded by the Horizon Europe Program. The systematic review method was used in this study. The methodology for this review was prepared according to PROSPERO. The study adhered to the 'Preferred Reporting Items for Systematic Reviews and Meta-Analyses" guidelines to ensure comprehensive and transparent reporting. It was found that the projects within this review aim to address a variety of challenges, including improving tumor identification and margin delineation, personalizing treatment plans, and automating surgical procedures. The projects analyzed in this systematic review represent a promising step forward in the development of AI-powered cancer surgery. These projects can significantly impact the field by improving surgical precision, personalizing treatment plans, and automating surgical procedures. The research also underscores the need for continued research and development, particularly in addressing challenges related to data integration, algorithmic transparency, and clinical implementation. As AI continues to permeate the healthcare landscape, its impact on cancer surgery is poised to be profound. The insights gleaned from this study provide a valuable roadmap for future research directions and clinical applications, paving the way for a future where AI empowers health professionals to deliver personalized, effective, and transformative cancer care.

Keywords

• horizon europe
• artificial intelligence
• cancer
• surgery
• european union